CA1240323A - Antiinflammatory salts of piroxicam - Google Patents
Antiinflammatory salts of piroxicamInfo
- Publication number
- CA1240323A CA1240323A CA000492570A CA492570A CA1240323A CA 1240323 A CA1240323 A CA 1240323A CA 000492570 A CA000492570 A CA 000492570A CA 492570 A CA492570 A CA 492570A CA 1240323 A CA1240323 A CA 1240323A
- Authority
- CA
- Canada
- Prior art keywords
- piroxicam
- salt
- methyl
- doxepin
- guanidino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
- C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/12—[b,e]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US659,733 | 1984-10-11 | ||
| US06/659,733 US4567179A (en) | 1984-10-11 | 1984-10-11 | Antiinflammatory salts of piroxicam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1240323A true CA1240323A (en) | 1988-08-09 |
Family
ID=24646598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000492570A Expired CA1240323A (en) | 1984-10-11 | 1985-10-09 | Antiinflammatory salts of piroxicam |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4567179A (de) |
| EP (1) | EP0178124B1 (de) |
| JP (1) | JPS6193182A (de) |
| KR (1) | KR870000277B1 (de) |
| CN (1) | CN1008062B (de) |
| AT (1) | ATE44147T1 (de) |
| AU (1) | AU553819B2 (de) |
| CA (1) | CA1240323A (de) |
| DD (1) | DD237658A5 (de) |
| DE (1) | DE3571132D1 (de) |
| DK (1) | DK463385A (de) |
| EG (1) | EG17673A (de) |
| FI (1) | FI82044C (de) |
| GR (1) | GR852457B (de) |
| HU (1) | HU193348B (de) |
| IE (1) | IE58722B1 (de) |
| IL (1) | IL76644A0 (de) |
| NO (1) | NO854033L (de) |
| NZ (1) | NZ213743A (de) |
| PH (1) | PH21594A (de) |
| PL (1) | PL255696A1 (de) |
| PT (1) | PT81279B (de) |
| SU (1) | SU1375136A3 (de) |
| YU (1) | YU44897B (de) |
| ZA (1) | ZA857785B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4812455A (en) * | 1984-10-11 | 1989-03-14 | Pfizer Inc. | Antiinflammatory compositions and methods |
| US5260333A (en) * | 1986-08-08 | 1993-11-09 | Bristol Myers Squibb Company | Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions |
| US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
| EP1169322B8 (de) | 1999-03-08 | 2006-09-13 | Medicure Inc. | Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel |
| EP1196171A2 (de) | 1999-07-13 | 2002-04-17 | Medicure Inc. | Verwendung der pyridoxin-derivaten zur behandlung von diabetes und komplikationen davon |
| EP1210117A2 (de) * | 1999-08-24 | 2002-06-05 | Medicure International Inc. | Zusammensetzungen zur behandlung von kardiovaskularen krankheiten die pyridoxal-derivate und kardiovaskuläre mittel enthalten |
| DE60133323T2 (de) | 2000-02-29 | 2009-03-05 | Medicure International Inc. | Cardioprotektive Phosphonate |
| US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| JP2003528146A (ja) | 2000-03-28 | 2003-09-24 | メディキュア インターナショナル インコーポレイテッド | 脳血管疾患の治療 |
| ATE364595T1 (de) | 2000-07-07 | 2007-07-15 | Medicure Int Inc | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika |
| US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
| US6897228B2 (en) * | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
| US20040121988A1 (en) * | 2001-03-28 | 2004-06-24 | Medicure International Inc. | Treatment of cerebrovascular disease |
| US20040186077A1 (en) * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents |
| CN101014357A (zh) * | 2004-07-07 | 2007-08-08 | 麦迪库瑞国际公司 | 利用血小板聚集药物的组合疗法 |
| US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
| US7459468B2 (en) * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
| EP1817288A4 (de) * | 2004-10-28 | 2009-08-26 | Medicure Int Inc | Duale antiplättchen-/antikoagulans-pyridoxinanaloge |
| US20060094749A1 (en) * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents |
| JP2009517411A (ja) * | 2005-11-28 | 2009-04-30 | メディキュア インターナショナル インコーポレーテッド | 心血管及び関連病状の処置のための調剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230717A (en) * | 1978-12-29 | 1980-10-28 | Lovelace Alan M Administrator | Indomethacin-antihistamine combination for gastric ulceration control |
| US4374843A (en) * | 1980-10-14 | 1983-02-22 | Pfizer Inc. | 2-Guanidino-4-heteroarylthiazoles |
| US4434163A (en) * | 1981-06-01 | 1984-02-28 | Pfizer Inc. | Water-soluble benzothiazine dioxide salts |
| GB2105193B (en) * | 1981-09-04 | 1984-09-12 | Glaxo Group Ltd | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
| BE894286A (fr) * | 1981-09-04 | 1983-03-02 | Glaxo Group Ltd | Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose |
-
1984
- 1984-10-11 US US06/659,733 patent/US4567179A/en not_active Expired - Fee Related
-
1985
- 1985-10-02 DE DE8585307059T patent/DE3571132D1/de not_active Expired
- 1985-10-02 AT AT85307059T patent/ATE44147T1/de not_active IP Right Cessation
- 1985-10-02 EP EP85307059A patent/EP0178124B1/de not_active Expired
- 1985-10-08 NZ NZ213743A patent/NZ213743A/xx unknown
- 1985-10-09 PL PL25569685A patent/PL255696A1/xx unknown
- 1985-10-09 ZA ZA857785A patent/ZA857785B/xx unknown
- 1985-10-09 PT PT81279A patent/PT81279B/pt unknown
- 1985-10-09 GR GR852457A patent/GR852457B/el unknown
- 1985-10-09 CA CA000492570A patent/CA1240323A/en not_active Expired
- 1985-10-10 SU SU853971352A patent/SU1375136A3/ru active
- 1985-10-10 DD DD85281614A patent/DD237658A5/de not_active IP Right Cessation
- 1985-10-10 IL IL76644A patent/IL76644A0/xx not_active IP Right Cessation
- 1985-10-10 HU HU853940A patent/HU193348B/hu not_active IP Right Cessation
- 1985-10-10 NO NO854033A patent/NO854033L/no unknown
- 1985-10-10 CN CN85107498A patent/CN1008062B/zh not_active Expired
- 1985-10-10 KR KR1019850007443A patent/KR870000277B1/ko not_active IP Right Cessation
- 1985-10-10 AU AU48484/85A patent/AU553819B2/en not_active Ceased
- 1985-10-10 IE IE249885A patent/IE58722B1/en not_active IP Right Cessation
- 1985-10-10 FI FI853946A patent/FI82044C/fi not_active IP Right Cessation
- 1985-10-10 EG EG645/85A patent/EG17673A/xx active
- 1985-10-10 DK DK463385A patent/DK463385A/da not_active Application Discontinuation
- 1985-10-10 PH PH32915A patent/PH21594A/en unknown
- 1985-10-10 YU YU1616/85A patent/YU44897B/xx unknown
- 1985-10-11 JP JP60226663A patent/JPS6193182A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1240323A (en) | Antiinflammatory salts of piroxicam | |
| US4283408A (en) | Guanidinothiazole compounds, process for preparation and gastric inhibiting compositions containing them | |
| JPH02117663A (ja) | ４―アミノ―３―キノリンカルボン酸類およびそのエステル類 | |
| US4376768A (en) | Benzothiazine derivative | |
| EP0051409B1 (de) | 2-(Phenyl-substituierte)-thiazol-Derivate und sie enthaltende Arzneimittel zur Behandlung von Geschwüren | |
| EP0039989B1 (de) | Pyrimidonderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
| US3896223A (en) | Anti-inflammatory thiazole compositions and methods for using same | |
| US4277496A (en) | Methods of treating mammals suffering from inflammation and pain | |
| EP0178121B1 (de) | Formulierung von entzündungshemmenden Arzneimitteln | |
| US4312869A (en) | Monosubstituted piperazines | |
| US4361567A (en) | Treatment of peptic ulcer disease | |
| PL130912B1 (en) | Process for preparing novel,water-soluble salts of 1,1-dioxide of n-/2-pyridyl/-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carbonamide with lysine or arginine | |
| EP0178822B1 (de) | 2-Guanidin-4-(2-methyl-4-imidazolyl)thiazole in der Behandlung von rheumatoider Arthritis | |
| PL132354B1 (en) | Process for preparing n-/5-tetrazolyl/-1-keto-1h-thiazolo/3,2-a/ pyrimidin-2-carbonamides | |
| US4447437A (en) | Pharmaceutical composition and method for treatment of peptic ulcer | |
| US4376119A (en) | Benzothiazine derivative | |
| US4359466A (en) | Guanidine compounds | |
| US4156009A (en) | Diazepine derivatives | |
| EP0394476B1 (de) | Neue 1,3,4,-thiadiazolderivate und antigeschwulstmittel, die diese enthalten | |
| CA1177484A (en) | Benzothiazine derivatives | |
| EP0028117A1 (de) | Guanidinverbindungen, Verfahren zu deren Herstellung und diese enthaltende Zusammensetzungen | |
| JPS58185560A (ja) | ２−ピロリン−３−カルボニトリル誘導体，その製造法および医薬組成物 | |
| JPS6191122A (ja) | ２―グアニジノ―４―（２―メチル―４―イミダゾリル）チアゾール類からなる慢性関節リウマチ治療用組成物 | |
| JPH03101647A (ja) | 新規なフェニル酢酸誘導体とその調製方法 | |
| HU194872B (en) | Process for production of pirasole-derivatives and medical preparatives containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |